Hydrocodone Bitartrate And Homatropine Methylbromide
Product Images NDC 66336-871

3 FDA label images from Dispensing Solutions, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Homatropine Methylbromide (NDC 66336-871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0871-xx (Ndc 66336 0871 Xx Novel)

Ndc 66336-0871-xx (Ndc 66336 0871 Xx      Novel)
Label for Hydrocodone Bitartrate and Homatropine Methylbromide tablets, 5 mg/1.5 mg strength, from Dispensing Solutions, Inc. It includes product and bulk source information, dosage instructions, and warnings. The label displays the NDC 66336-0871, indicates the tablets are prescription-only, and highlights manufacturer and packaging details.*
FDA Label Image

Image Description (C1519135 Figure 01)

Image Description (C1519135 Figure 01)
Chemical structure diagram showing the molecular formulas of Hydrocodone Bitartrate and Homatropine Methylbromide, including the hydrate component. The image depicts the detailed chemical bonds and arrangement of atoms in these compounds.*
FDA Label Image

Image Description (C1519135 Figure 02)

Image Description (C1519135 Figure 02)
Chemical structure of Hydrocodone Bitartrate and Homatropine Methylbromide showing the molecular arrangement including a tropane ring with a methylammonium group and a benzene ring attached to a carboxyl group with a hydroxyl substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.